Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion type Assertion NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_head.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion wasGeneratedBy ECO_0000203 NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_provenance.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion wasDerivedFrom befree-2016 NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_provenance.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion SIO_000772 24847764 NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_provenance.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion evidence source_evidence_literature NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_provenance.
- NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_assertion description "[A series of preclinical studies have demonstrated the superiority of the Ad/PSA vaccine to other PSA vaccines for the induction of anti-PSA immune responses, the ability of Ad/PSA vaccination combined with cytokine gene therapy and the TLR9 agonist CpG to enhance the anti-prostate tumor immunotherapy, and the reduction of negative regulatory elements when the vaccine was combined with 5-fluoruracil administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184303.RA5cqTnumOTYD76hDK9nliyLnhRJSnoXoT8C22G_cabCk130_provenance.